Advertisement
New Zealand markets closed
  • NZX 50

    11,809.48
    +77.20 (+0.66%)
     
  • NZD/USD

    0.6117
    +0.0020 (+0.33%)
     
  • NZD/EUR

    0.5649
    +0.0021 (+0.37%)
     
  • ALL ORDS

    8,081.70
    -36.60 (-0.45%)
     
  • ASX 200

    7,810.80
    -37.30 (-0.48%)
     
  • OIL

    76.93
    -0.64 (-0.83%)
     
  • GOLD

    2,365.90
    -27.00 (-1.13%)
     
  • NASDAQ

    18,705.20
    -8.59 (-0.05%)
     
  • FTSE

    8,370.33
    -46.12 (-0.55%)
     
  • Dow Jones

    39,671.04
    -201.95 (-0.51%)
     
  • DAX

    18,680.20
    -46.56 (-0.25%)
     
  • Hang Seng

    18,851.86
    -343.74 (-1.79%)
     
  • NIKKEI 225

    39,053.00
    +435.90 (+1.13%)
     
  • NZD/JPY

    95.8390
    +0.3360 (+0.35%)
     

Why Celestica (CLS) Might be Well Poised for a Surge

Celestica (CLS) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.

The upward trend in estimate revisions for this electronics manufacturing services company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- has this insight at its core.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For Celestica, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.

ADVERTISEMENT

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate Revisions

The earnings estimate of $0.81 per share for the current quarter represents a change of +47.27% from the number reported a year ago.

The Zacks Consensus Estimate for Celestica has increased 13.71% over the last 30 days, as two estimates have gone higher compared to no negative revisions.

Current-Year Estimate Revisions

For the full year, the earnings estimate of $3.32 per share represents a change of +36.63% from the year-ago number.

In terms of estimate revisions, the trend for the current year also appears quite encouraging for Celestica. Over the past month, two estimates have moved higher compared to no negative revisions, helping the consensus estimate increase 10.62%.

Favorable Zacks Rank

The promising estimate revisions have helped Celestica earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

Investors have been betting on Celestica because of its solid estimate revisions, as evident from the stock's 7.1% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Celestica, Inc. (CLS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research